Interim Report Q2, 2023: Calliditas Therapeutics


Filing for full approval of TARPEYO STOCKHOLM, Aug. 17, 2023 /PRNewswire/ — FINANCIAL SUMMARY FOR THE GROUP Key Figures April 1 – June 30, 2023 Net sales amounted to SEK 269.4 million, of which TARPEYO® net sales amounted to SEK 259.2 million, for the three months ended June 30, 2023….

Leave a Reply